Noncoding RNAs in the COVID-19 Saga: An Untold Story
Mudasir Maqbool, Md Sadique Hussain, Nusrat K. Shaikh, Ayesha Sultana, Ajay Singh Bisht, Mohit Agrawal
Abstract
In late 2019, the SARS-CoV-2 virus emerged as the cause of COVID-19, triggering a worldwide pandemic of unprecedented scale. A detailed comprehension is being established to elucidate the severe immunopathological condition in critical cases of COVID-19. Noncoding RNAs (ncRNAs) are the transcribed but untranslated part of the genome that used to be ignored or disregarded until recent times. The latest research has revealed the intricate role played by the immune system in responding to SARS-CoV-2 and the development of COVID-19, affecting important aspects such as cytokine storm syndrome, changes in blood clotting, attraction of immune cells, and regulation of blood vessels. Exploring the possibilities of host–virus RNA interactions and RNA-RBP interactions has garnered significant interest. Following SARS-CoV-2 infection, the levels of certain ncRNAs change to indirectly control the expression of antiviral genes and viral gene replication. Certain ncRNAs are utilized by SARS-CoV-2 to assist the virus in evading the immune system by reducing the production of type I interferon (IFN-1) and regulating cytokine levels.